IKIO Technologies Ltd
IKIOIKIO Technologies Ltd's earnings have outrun its stock. EPS grew +28.1% in a year against a +1.0% price move.
The sharpest disagreement: profits are rising, but only 34% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a downtrend (152 weeks in) while the P/E sits at the 39th percentile of its own 3-year range. Underneath, the last four quarters read improving, and 34% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
IKIO Technologies Ltd trades at ₹200, in a downtrend and 152 weeks into that stage. That is +14.0% against its own 200-day average. It sits at 77% of a 52-week range of ₹109 to ₹228. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 5 straight weeks.
Today the stock is in a downtrend — week 152 of stage 4. At ₹200 it trades +14.0% versus its 200-day average and sits at 77% of its 52-week range (₹109–₹228).
Against the market, two honest reads. Cumulative: over the last 3.1 years the stock moved −50% while the NIFTY 500 moved +44% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 5 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
IKIO Technologies Ltd trades at 37.4× P/E, mid-range by its own standards (39th percentile). Its long-run median P/E is 39.2×, measured across 3.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 37.4× is mid-range by its own standards (39th percentile), against a long-run median of 39.2× measured over 3.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +28.1% against a +1.0% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the −22.0%/yr price move, ~−35.8%/yr came from earnings growth and ~+13.8 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
IKIO Technologies Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −83.3% at the trough to +37.5%, a 2-quarter improving streak (single-quarter readings), ROCE holding at 9.0%. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +22.4% | +18.3% | +22.8% | — |
| Profit | +31.3% | −5.6% | +7.7% | — |
| EPS | +28.1% | −11.3% | −75.2% | — |
| Share price | +1.0% | −22.0% | — | — |
4-Factor Sector Score
53.6/100 — rank 9 of 19 in Capital Goods - Electric General · 75% evidence confidence
IKIO Technologies Ltd scores 53.6 out of 100 against the 19 companies it is compared with in Capital Goods - Electric General, ranking 9. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 22.1 + 9.7 + 8.4 + 13.4 = 53.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
IKIO Technologies Ltd reported ₹165 Cr of revenue in the Mar 26 quarter, +47.3% year on year. That is the 3rd straight quarter of year-on-year growth. Over 6 years it has compounded at 18.0% a year. The last full year, FY26, came in at ₹595 Cr. The last four reported quarters add to ₹595 Cr.
FY26 revenue came in at ₹595 Cr (+22.4% on the year), capping 6 years at 18.0% compound. The latest quarter (Mar 26) printed ₹165 Cr, +47.3% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +23.2% growth against the decade's 18.0% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +22.4% over the last 4 quarters against +16.6%/yr over the last 8 — accelerating; TTM profit +31.3% vs −17.0%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
IKIO Technologies Ltd's operating margin is 16.0% in the Mar 26 quarter, +10.0 percentage points against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 12.0% to 23.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 16.0%, +10.0 pp against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 12.0%–23.0%.
Why the margin moved: operating margin went +10.2 pp year on year while gross margin went −0.3 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
IKIO Technologies Ltd earned ₹18.0 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹42.0 Cr. The 6-year compound rate is 12.2%. That is 10.9% of the quarter's revenue. The same quarter a year earlier lost ₹1.0 Cr. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was ₹18.0 Cr, null year on year. On the full year, FY26 printed ₹42.0 Cr (+31.3%), and the 6-year compound rate is 12.2%.
Pace comparison, last four quarters: profit −20.4% vs revenue +23.2%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 34% of IKIO Technologies Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹16.0 Cr of operating cash against ₹42.0 Cr of profit. After ₹83.0 Cr of capital spending, ₹−67.0 Cr was left as free cash.
FY26: operating cash of ₹16.0 Cr against reported profit of ₹42.0 Cr, leaving free cash of ₹−67.0 Cr after ₹83.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 34% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 34%: the cash cycle stretched 92 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 92 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
IKIO Technologies Ltd's cash conversion cycle runs 253 days in FY26, up from 161 days in FY21. Capital spending ran ₹275 Cr over the last 3 years. At FY26 sales of ₹595 Cr each day of that cycle holds about ₹1.6 Cr, so roughly ₹412 Cr sits inside the business at any moment.
FY26: debtors at 82 days, inventory at 218 days — roughly 7.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 253 days, looser than FY21's 161.
The full loop: cash goes out to suppliers and production on day 0; stock waits 218 days to sell; customers pay about 82 days after that; and suppliers themselves are paid at 46 days — netting out to the 253-day cycle.
In money terms: at FY26 sales of ₹595 Cr, each day of the cycle holds about ₹1.6 Cr — so the 253-day loop keeps roughly ₹412 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹275 Cr over the last 3 fiscal years against ₹67.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹101 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
IKIO Technologies Ltd earns a ROCE of 9% in FY26. That is up from a trough of 8% in FY25. Return on invested capital clears the cost of that capital by −5.9 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 7.1% net margin on 0.76× asset turns.
FY26 ROCE is 9%, recovered from a FY25 trough of 8% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 7.1% net margin × 0.76× asset turns × 1.29× balance-sheet leverage ≈ 7.0% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 6.1% − 12.0% = a −5.9 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
IKIO Technologies Ltd carries total debt of ₹70.0 Cr against shareholder equity of ₹609 Cr as of Mar 26, a debt-to-equity of 0.11 — effectively unlevered. On the annual view that ratio went from 0.89 in FY23 to 0.11 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹70.0 Cr against shareholder equity of ₹609 Cr — a debt-to-equity of 0.11. On the annual view, debt-to-equity went from 0.89 (FY23) to 0.11 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions cut 4.2 points of IKIO Technologies Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 0.9% of the company. Promoters moved +0.0 points over the same window, to 72.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: −4.2 points over 8 quarters to 0.9%; Promoters: +0.0 points over 8 quarters to 72.5%; Foreign institutions: +0.0 points over 8 quarters to 0.7%.
🚨 Why the register moved: domestic institutions drove it (−4.2 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
IKIO Technologies Ltd: the Z-score reads 7.47. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 7.47 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 7.47.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Modison LtdMODISONLTD | 79.1/100Favorable setup83% evidence | LEADER | 29.2/35 Revenue 45.2% · PAT 100% · OPM change 13 pp 83% evidence | 18.5/25 ROCE 31% · OPM 25% 95% evidence | 12.9/20 P/E 11.1× · PEG — 50% evidence | 18.5/20 RS sector 32.5% · RS bench 47.4% · 1Y 49.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 29.2 + 18.5 + 12.9 + 18.5 = 79.1 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Rishabh Instruments LtdRISHABH | 68.6/100Favorable setup86% evidence | LEADER | 25.7/35 Revenue 7.8% · PAT 100% · OPM change 7 pp 88% evidence | 16.4/25 ROCE 14.5% · OPM 16% 100% evidence | 11.1/20 P/E 29× · PEG — 50% evidence | 15.4/20 RS sector 19.1% · RS bench 34.3% · 1Y 114.3%12 of 12 weeks ahead 100% evidence |
| Exact sum: 25.7 + 16.4 + 11.1 + 15.4 = 68.6 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3Modern Insulators LtdMODINSULAT | 66.8/100Favorable setup78% evidence | LEADER | 28.0/35 Revenue 42.7% · PAT 100% · OPM change 5 pp 83% evidence | 17.8/25 ROCE 19.4% · OPM 16% 76% evidence | 7.0/20 P/E 28× · PEG — 50% evidence | 14.0/20 RS sector 62.8% · RS bench 81.2% · 1Y 404.3%12 of 12 weeks ahead 100% evidence |
| Exact sum: 28 + 17.8 + 7 + 14 = 66.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 4Ravindra Energy LtdRELTD | 65.9/100Favorable setup83% evidence | TURNING | 28.3/35 Revenue 100% · PAT 100% · OPM change 8 pp 88% evidence | 15.7/25 ROCE 15.9% · OPM 25% 100% evidence | 8.2/20 P/E 41.4× · PEG 1.97 65% evidence | 13.7/20 RS sector 6.9% · RS bench 12% · 1Y 19.3%5 of 10 weeks ahead 70% evidence |
| Exact sum: 28.3 + 15.7 + 8.2 + 13.7 = 65.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Spectrum Electrical Industries LtdSPECTRUM | 64.7/100Mixed-positive evidence96% evidence | BREAKING OUT | 23.4/35 Revenue 52% · PAT 92.3% · OPM change 1 pp 88% evidence | 17.5/25 ROCE 16.8% · OPM 16% 100% evidence | 4.3/20 P/E 83.6× · PEG 9.09 100% evidence | 19.5/20 RS sector 43% · RS bench 61.5% · 1Y 51%10 of 12 weeks ahead 100% evidence |
| Exact sum: 23.4 + 17.5 + 4.3 + 19.5 = 64.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 6Kirloskar Electric Company LtdKECL | 58.2/100Mixed-positive evidence68% evidence | TURNING | 21.3/35 Revenue 8.4% · PAT 100% · OPM change 3.4 pp 62% evidence | 12.5/25 ROCE 14.6% · OPM 3.9% 95% evidence | 8.7/20 P/E 105× · PEG — 15% evidence | 15.7/20 RS sector 10.9% · RS bench 25.3% · 1Y 4.4%10 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 12.5 + 8.7 + 15.7 = 58.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Insolation Energy LtdINA | 57.9/100Mixed-positive evidence90% evidence | ASLEEP | 18.4/35 Revenue 62.7% · PAT 61% · OPM change 0 pp 88% evidence | 16.9/25 ROCE 22.2% · OPM 14% 100% evidence | 19.6/20 P/E 12.3× · PEG 0.23 100% evidence | 3.0/20 RS sector -39.8% · RS bench -22.8% · 1Y -52.1%7 of 11 weeks ahead 70% evidence |
| Exact sum: 18.4 + 16.9 + 19.6 + 3 = 57.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Alpex Solar LtdALPEXSOLAR | 53.7/100Mixed-positive evidence70% evidence | ASLEEP | 17.3/35 Revenue 100% · PAT 100% · OPM change -3 pp 83% evidence | 18.3/25 ROCE 43.5% · OPM 13% 95% evidence | 11.5/20 P/E 10.5× · PEG — 15% evidence | 6.6/20 RS sector -2.9% · RS bench -17.7% · 1Y -33.8%7 of 10 weeks ahead 70% evidence |
| Exact sum: 17.3 + 18.3 + 11.5 + 6.6 = 53.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9IKIO Technologies Ltdthis pageIKIO | 53.6/100Mixed-positive evidence75% evidence | BREAKING OUT | 22.1/35 Revenue 22.4% · PAT 31.3% · OPM change 10 pp 62% evidence | 9.7/25 ROCE 9.5% · OPM 16% 95% evidence | 8.4/20 P/E 37.4× · PEG — 50% evidence | 13.4/20 RS sector -0.9% · RS bench 12.1% · 1Y -3%12 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 9.7 + 8.4 + 13.4 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Siemens LtdSIEMENS | 48.6/100Mixed-negative evidence78% evidence | FADING | 15.9/35 Revenue 13.4% · PAT -40.3% · OPM change -1 pp 83% evidence | 17.3/25 ROCE 21.4% · OPM 10% 76% evidence | 7.3/20 P/E 47.7× · PEG — 50% evidence | 8.1/20 RS sector -1.8% · RS bench 11.6% · 1Y 23.8%7 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 17.3 + 7.3 + 8.1 = 48.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Swelect Energy Systems LtdSWELECTES | 48.2/100Mixed-negative evidence70% evidence | ASLEEP | 21.8/35 Revenue 5.6% · PAT 100% · OPM change 5 pp 83% evidence | 9.1/25 ROCE 8% · OPM 18% 95% evidence | 11.0/20 P/E 19× · PEG — 15% evidence | 6.3/20 RS sector -4.4% · RS bench -11.8% · 1Y -11.8%7 of 10 weeks ahead 70% evidence |
| Exact sum: 21.8 + 9.1 + 11 + 6.3 = 48.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12V-Guard Industries LtdVGUARD | 48.1/100Mixed-negative evidence100% evidence | BASING | 19.0/35 Revenue 13.4% · PAT 26.4% · OPM change 3 pp 100% evidence | 15.0/25 ROCE 18.4% · OPM 11% 100% evidence | 9.6/20 P/E 36.2× · PEG 2.51 100% evidence | 4.5/20 RS sector -18.5% · RS bench -6.9% · 1Y -21.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 15 + 9.6 + 4.5 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Exicom Tele-Systems LtdEXICOM | 43.2/100Mixed-negative evidence68% evidence | BREAKING OUT | 16.4/35 Revenue 32.7% · PAT -80% · OPM change 6.1 pp 65% evidence | 0.3/25 ROCE -14.7% · OPM 0.1% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 16.5/20 RS sector 9.4% · RS bench 22.7% · 1Y -3.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 0.3 + 10 + 16.5 = 43.2 · Decision use: Price leads the evidence: RS versus the benchmark is 22.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 14HPL Electric & Power LtdHPL | 39.4/100Mixed-negative evidence77% evidence | ASLEEP | 11.0/35 Revenue 6.5% · PAT -3.2% · OPM change 0 pp 83% evidence | 14.1/25 ROCE 13.5% · OPM 17% 95% evidence | 10.4/20 P/E 22.5× · PEG — 50% evidence | 3.9/20 RS sector -22.8% · RS bench -15.3% · 1Y -40.2%4 of 10 weeks ahead 70% evidence |
| Exact sum: 11 + 14.1 + 10.4 + 3.9 = 39.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Servotech Renewable Power System LtdSERVOTECH | 38.3/100Mixed-negative evidence82% evidence | ASLEEP | 12.6/35 Revenue 7.4% · PAT 7.5% · OPM change 1.9 pp 95% evidence | 11.4/25 ROCE 12.8% · OPM 9.5% 76% evidence | 11.5/20 P/E 51.8× · PEG — 50% evidence | 2.8/20 RS sector -21.6% · RS bench -11.8% · 1Y -37.9%10 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 11.4 + 11.5 + 2.8 = 38.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Honda India Power Products LtdHONDAPOWER | 38.0/100Mixed-negative evidence81% evidence | ASLEEP | 16.2/35 Revenue 11.8% · PAT -9.6% · OPM change 3 pp 95% evidence | 7.6/25 ROCE 11.5% · OPM 8% 95% evidence | 7.6/20 P/E 29× · PEG — 50% evidence | 6.6/20 RS sector -4% · RS bench -12.6% · 1Y -26.5%1 of 10 weeks ahead 70% evidence |
| Exact sum: 16.2 + 7.6 + 7.6 + 6.6 = 38 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Salzer Electronics LtdSALZERELEC | 37.5/100Mixed-negative evidence77% evidence | ASLEEP | 14.2/35 Revenue 24% · PAT -22.1% · OPM change -1 pp 83% evidence | 8.7/25 ROCE 11.5% · OPM 7% 95% evidence | 9.9/20 P/E 19.4× · PEG — 50% evidence | 4.7/20 RS sector -19.7% · RS bench -16.5% · 1Y -28.6%4 of 10 weeks ahead 70% evidence |
| Exact sum: 14.2 + 8.7 + 9.9 + 4.7 = 37.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Focus Lighting & Fixtures LtdFOCUS | 31.6/100Adverse evidence61% evidence | ASLEEP | 7.0/35 Revenue 2.4% · PAT -66.6% · OPM change 0.9 pp 83% evidence | 7.5/25 ROCE 5.5% · OPM 10.2% 95% evidence | 8.9/20 P/E 93.4× · PEG — 15% evidence | 8.2/20 RS sector — · RS bench -13.2% · 1Y —0 of 3 weeks ahead 25% evidence |
| Exact sum: 7 + 7.5 + 8.9 + 8.2 = 31.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Igarashi Motors India LtdIGARASHI | 30.9/100Adverse evidence70% evidence | TURNING | 7.8/35 Revenue 3.3% · PAT -49.8% · OPM change -1.9 pp 83% evidence | 7.4/25 ROCE 4.6% · OPM 8.5% 95% evidence | 8.5/20 P/E 117× · PEG — 15% evidence | 7.2/20 RS sector -19.7% · RS bench 3.6% · 1Y -25.3%9 of 10 weeks ahead 70% evidence |
| Exact sum: 7.8 + 7.4 + 8.5 + 7.2 = 30.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is IKIO Technologies Ltd's share price today?
IKIO Technologies Ltd trades at ₹200, +1.0% over the past year. The company is valued at ₹1,547 Cr. The stock sits at 77% of its 52-week range of ₹109–₹228, +14.0% versus its 200-day average. On the tape, the price is in a downtrend, 152 weeks in. — as of 31 July 2026.
What were IKIO Technologies Ltd's latest quarterly results?
IKIO Technologies Ltd reported revenue of ₹165 Cr and net profit of ₹18.0 Cr for the Mar 26 quarter. Earnings per share were ₹2.13. The operating margin was 16.0%, 10.0 pp higher than a year earlier. — as of 31 July 2026.
What is IKIO Technologies Ltd's revenue?
IKIO Technologies Ltd reported revenue of ₹165 Cr in the Mar 26 quarter, +47.3% year on year. For the full FY26 fiscal year, revenue was ₹595 Cr (+22.4%). Over the last 6 years revenue compounded at 18.0% a year. — as of 31 July 2026.
What is IKIO Technologies Ltd's profit?
IKIO Technologies Ltd earned ₹18.0 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹42.0 Cr. The operating margin ran 16.0% in the latest quarter. — as of 31 July 2026.
What is IKIO Technologies Ltd's market cap?
IKIO Technologies Ltd's market capitalisation is ₹1,547 Cr at a share price of ₹200. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is IKIO Technologies Ltd's P/E ratio?
IKIO Technologies Ltd trades at a P/E of 37.4×, at the 39th percentile of its own 3-year range, against a long-run median of 39.2×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does IKIO Technologies Ltd pay a dividend?
Not in its latest year — IKIO Technologies Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 1 of its last 7 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is IKIO Technologies Ltd overvalued?
On its own history, IKIO Technologies Ltd looks mid-range against its own history: its P/E of 37.4× sits at the 39th percentile of its 3-year range (long-run median 39.2×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
How is IKIO Technologies Ltd performing?
IKIO Technologies Ltd is in a downtrend, 152 weeks in. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 5 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is IKIO Technologies Ltd in?
Turning around — profit growth swung from −83.3% at the trough to +37.5%, a 2-quarter improving streak (single-quarter readings), ROCE holding at 9.0%. The read comes from the last 12 quarters of growth (revenue growth +47.3% latest, profit growth +37.5% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is IKIO Technologies Ltd in an uptrend?
No — the price is in a downtrend (week 152 of stage 4), trading +14.0% versus its 200-day average and at 77% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is IKIO Technologies Ltd beating the market?
On recent form, yes — IKIO Technologies Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 5 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 3.1 years the stock moved −50% against the NIFTY 500's +44% — behind the index over the full window. — as of 31 July 2026.
Will IKIO Technologies Ltd's share price go up?
This page publishes no price forecast for IKIO Technologies Ltd. What it measures instead: the share price is ₹200, the price is in a downtrend 152 weeks in. Its P/E of 37.4× sits at the 39th percentile of its own 3-year range. — as of 31 July 2026.
Who owns IKIO Technologies Ltd?
Promoters hold 72.5% of IKIO Technologies Ltd, foreign institutions 0.7%, domestic institutions 0.9% and the public 25.9% (latest quarter). The biggest move on the register over the last two years: Domestic institutions cut 4.2 points over 8 quarters. — as of 31 July 2026.
Does IKIO Technologies Ltd have too much debt?
No — IKIO Technologies Ltd's debt-to-equity is 0.12, and operating profit covers the interest bill 9×. FY26 borrowings were ₹70.0 Cr against equity of ₹602 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is IKIO Technologies Ltd's capex?
IKIO Technologies Ltd spent ₹275 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹83.0 Cr, with ₹101 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is IKIO Technologies Ltd's cash flow?
IKIO Technologies Ltd generated ₹16.0 Cr of operating cash flow in FY26 and ₹−67.0 Cr of free cash flow after ₹83.0 Cr of capital spending. Reported profit that year was ₹42.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is IKIO Technologies Ltd's profit real cash?
Not fully — over the last 3 fiscal years, 34% of IKIO Technologies Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹16.0 Cr against reported profit of ₹42.0 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 31 July 2026.
How financially safe is IKIO Technologies Ltd?
On the balance sheet, the Z-score reads 7.47 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 31 July 2026.
Where is IKIO Technologies Ltd in its business cycle?
IKIO Technologies Ltd's FY26 operating margin was 13.0%, against a 7-year band of 12.0%–23.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 16.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the IKIO Technologies Ltd story?
The sharpest disagreement: profits are rising, but only 34% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is IKIO Technologies Ltd a stock worth studying right now?
This is not investment advice. The machine read: IKIO Technologies Ltd's earnings have outrun its stock. EPS grew +28.1% in a year against a +1.0% price move. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.